Alternatives to QR Genetics

AI-powered platform for understanding disease biology and accelerating drug discovery.

AI-guided drug discovery platform for tissue-targeted medicines.

Mapping cell-cell communication at scale in human tissue.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Gene therapy company developing treatments for rare inherited diseases.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Develops advanced gene editing and cell therapy solutions for rare genetic diseases.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Leveraging the adaptive immune system to diagnose and treat disease.

A global oncology company developing and commercializing innovative cancer treatments.

AI-powered platform for real-time organ physiology to accelerate human-relevant drug discovery.